[4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate

C39H52N6O5 — CID 146457691

IUPAC[4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate
SMILESCOc1ccc(C23CCC(CN(C(=O)C4CCC(OC(=O)N5CC(O)C5)CC4)c4cncc(-c5cnn(C(C)(C)C)c5)n4)(CC2)CC3)cc1C
InChIInChI=1S/C39H52N6O5/c1-26-18-29(8-11-33(26)49-5)39-15-12-38(13-16-39,14-17-39)25-44(34-21-40-20-32(42-34)28-19-41-45(22-28)37(2,3)4)35(47)27-6-9-31(10-7-27)50-36(48)43-23-30(46)24-43/h8,11,18-22,27,30-31,46H,6-7,9-10,12-17,23-25H2,1-5H3
InChIKeyRFMDBELHPCZZLL-UHFFFAOYSA-N
MW684.88 g/mol
LogP6.41
Rot. Bonds8

About [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate

[4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate (PubChem CID 146457691) has the molecular formula C39H52N6O5 and a molecular weight of 684.88 g/mol. Its IUPAC name is [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate.

Molecular Properties

Compound Name[4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate
PubChem CID146457691
Molecular FormulaC39H52N6O5
Molecular Weight684.88 g/mol
Exact Mass684.40
IUPAC Name[4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate
SMILESCOc1ccc(C23CCC(CN(C(=O)C4CCC(OC(=O)N5CC(O)C5)CC4)c4cncc(-c5cnn(C(C)(C)C)c5)n4)(CC2)CC3)cc1C
InChIInChI=1S/C39H52N6O5/c1-26-18-29(8-11-33(26)49-5)39-15-12-38(13-16-39,14-17-39)25-44(34-21-40-20-32(42-34)28-19-41-45(22-28)37(2,3)4)35(47)27-6-9-31(10-7-27)50-36(48)43-23-30(46)24-43/h8,11,18-22,27,30-31,46H,6-7,9-10,12-17,23-25H2,1-5H3
InChIKeyRFMDBELHPCZZLL-UHFFFAOYSA-N
XLogP6.41
TPSA122.91 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500684.88
LogP ≤ 56.41
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate?
The IUPAC name of [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate (CID 146457691) is [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate.
What is the SMILES notation for [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate?
The canonical SMILES for [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate is COc1ccc(C23CCC(CN(C(=O)C4CCC(OC(=O)N5CC(O)C5)CC4)c4cncc(-c5cnn(C(C)(C)C)c5)n4)(CC2)CC3)cc1C.
What is the InChIKey of [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate?
The InChIKey is RFMDBELHPCZZLL-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H52N6O5/c1-26-18-29(8-11-33(26)49-5)39-15-12-38(13-16-39,14-17-39)25-44(34-21-40-20-32(42-34)28-19-41-45(22-28)37(2,3)4)35(47)27-6-9-31(10-7-27)50-36(48)43-23-30(46)24-43/h8,11,18-22,27,30-31,46H,6-7,9-10,12-17,23-25H2,1-5H3.
What are the key properties of [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate?
[4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate has a molecular weight of 684.88 g/mol, XLogP of 6.41, 8 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[6-(1-tert-butylpyrazol-4-yl)pyrazin-2-yl]-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl]carbamoyl]cyclohexyl] 3-hydroxyazetidine-1-carboxylate is sourced from PubChem (CID 146457691), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).